>>>welcome visitor, haven't logged in. Login
Subscribe Now Contact us  
Font Size:  A A A Search “Fabao” Window English 中文 = 简体  繁体
  Favorite   DownLoad   Print
 
No. 5 of Trial of Five Typical Cases on Food and Pharmaceutical Product Dispute Issued by the Supreme People's Court: Wang Quan v. Eastern Nephropathy Hospital (Dispute over compensation for mail-order pharmaceutical products)
最高人民法院公布五起审理食品药品纠纷典型案例之五:王泉诉东方肾脏病医院邮购药品赔偿纠纷案
【法宝引证码】

No. 5 of Trial of Five Typical Cases on Food and Pharmaceutical Product Dispute Issued by the Supreme People's Court: Wang Quan v. Eastern Nephropathy Hospital (Dispute over compensation for mail-order pharmaceutical products)
(Dispute over compensation for mail-order pharmaceutical products)
最高人民法院公布五起审理食品药品纠纷典型案例之五:王泉诉东方肾脏病医院邮购药品赔偿纠纷案
No. 5 of Trial of Five Typical Cases on Food and Pharmaceutical Product Dispute Issued by the Supreme People's Court: Wang Quan v. Eastern Nephropathy Hospital (Dispute over compensation for mail-order pharmaceutical products) 最高人民法院公布五起审理食品药品纠纷典型案例之五:王泉诉东方肾脏病医院邮购药品赔偿纠纷案
1. Basic Facts (一)基本案情
The Eastern Nephropathy Hospital (hereinafter referred to as the “Nephropathy Hospital”) published an advertisement named New Hope for Curing Nephropathy and Uremia—Therapy of Eastern Nephropathy Hospital for Holographic Radical Treatment. This advertisement introduced the features, curative effect, and treatment methods of the traditional Chinese therapy for holographic radical treatment of nephropathy and uremia. After having read the advertisement, Wang Quan consulted the Nephropathy Hospital and the Hospital replied the consultation letters of Wang Quan, stating that its traditional Chinese therapy for holographic radical treatment could fundamentally cure nephropathy. From September 2003 to September 2004, Wang Quan purchased “Eastern Shengli Medicinal Powder,” “Eastern Nephropathy Capsule” and “GS Holographic Therapeutic Apparatus” valued at 20,180 yuan in a mail order from the Nephropathy Hospital. After having taken the pharmaceutical products and used the therapeutic apparatus he purchased, Wang Quan's conditions were not improved. In February 2005, Wang Quan reported the false advertising of the Nephropathy Hospital to the Administration for Industry and Commerce of Weifang City, Shandong Province. The Administration for Industry and Commerce of Weifang City made a reply that it has initiated an investigation on the problems of the Nephropathy Hospital for its illegal issuance of advertisements for medical treatment and internal preparations, and ordered the Nephropathy Hospital to terminate its illegal issuance of such advertisements. Therefore, Wang Quan filed a lawsuit in the People's Court of Jiangyang District, Luzhou City, Sichuan Province and claimed that the Nephropathy Hospital and the Sichuan Daily should refund 40,360 yuan, which was two times of the medical expenses. In the trial of first instance, Wang Quan withdrew his lawsuit against the Sichuan Daily. 东方肾脏病医院(以下简称肾病医院)在《四川日报》刊登了《治疗肾脏病尿毒症的新希望<东方肾脏病医院全息根治疗法>》,该广告对肾脏病、尿毒症的中医全息根治疗法的特点、疗效、治疗方式等进行了介绍,王泉看到这则广告后,向肾病医院进行了咨询,该医院对王泉的咨询信件作了回复,内容 为其医院中医全息根治疗法能从根本上治疗肾脏病。2003年10月-2004年10月,王泉向肾病医院邮购价值20180元的“东方生力散”、“东方肾病胶囊”和“GS系列全息治疗仪”。王泉服用所购药品并使用所购治疗仪后,病情未得到改善。2005年2月,王泉以肾病医院的广告宣传不实,向山东省潍坊市工商行政管理局作了反映,该局回复已对肾病医院违反广告法发布的医疗、内部制剂广告问题进行了立案调查处理,并责令其停止发布违法广告。据此,王泉向四川省泸州市江阳区人民法院起诉,要求肾病医院和《四川日报》双倍返还医疗费用40360元。一审中王泉撤回对四川日报社的起诉。
...... ......

Dear visitor, as a premium member of this database, you will get complete access to all content.Please go premium and get more.

1. To become a premium member, please call 400-810-8266 Ext. 171.

2. Binding to the account with access to this database.

3. Apply for a trial account.

4. To get instant access to a document, you can Pay Amount 【¥200.00】 for your single purchase.
 
您好:您现在要进入的是北大法宝英文库会员专区。
如您是我们英文用户可直接 登录,进入会员专区查询您所需要的信息;如您还不是我们 的英文用户;您可通过网上支付进行单篇购买,支付成功后即可立即查看本篇内容。
Tel: +86 (10) 82689699, +86 (10) 82668266 ext. 153
Mobile: +86 13311570713
Fax: +86 (10) 82668268
E-mail:info@chinalawinfo.com
     
     
Scan QR Code and Read on Mobile
【法宝引证码】        北大法宝en.pkulaw.cn
Message: Please kindly comment on the present translation.
 
Confirmation Code:
Click image to reset code
 
  Translations are by lawinfochina.com, and we retain exclusive copyright over content found on our website except for content we publish as authorized by respective copyright owners or content that is publicly available from government sources.

Due to differences in language, legal systems, and culture, English translations of Chinese law are for reference purposes only. Please use the official Chinese-language versions as the final authority. Lawinfochina.com and its staff will not be directly or indirectly liable for use of materials found on this website.

We welcome your comments and suggestions, which assist us in continuing to improve the quality of our materials as we dynamically expand content.
 
Home | About us | Disclaimer | Chinese